A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

BACKGROUND: There is uncertainty regarding the safety and effectiveness of direct oral anticoagulant agents in patients with antiphospholipid syndrome (APS). We performed a multicenter feasibility study to examine our ability to identify and obtain consent from eligible APS patients and to obtain 95...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pilot Feasibility Stud
Asıl Yazarlar: Legault, Kimberly, Blostein, Mark, Carrier, Marc, Khan, Susan, Schulman, Sam, Shivakumar, Sudeep, Wu, Cynthia, Crowther, Mark A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7183116/
https://ncbi.nlm.nih.gov/pubmed/32346486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40814-020-00594-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller